Today's edition of Market Checkup focuses on EU drug approvals for struggling biotech Dendreon and big pharma company Sanofi, and a controversial dividend stock to watch.
More dividend stock ideas
One of the best parts of owning big pharma stocks is their attractive dividends, but smart investors know the importance of diversifying -- seeking high-yielding stocks from multiple industries. The Motley Fool's special free report "Secure Your Future With 9 Rock-Solid Dividend Stocks" outlines the Fool's favorite dependable dividend-paying stocks across all sectors. Grab your free copy by clicking here.
Note: At 6:38, the speaker incorrectly states that Sanofi had a partnership with biotech company Rigel. The Fool regrets the error.